DocPharm
Posted - 2 days ago
$ROIV weeee I’ll get to add
Stock_Titan
Posted - 2 days ago
$ROIV $ROIVW Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and Provide Business Update on Thursday, May 30, 2024
https://www.stocktitan.net/news/ROIV/roivant-to-report-financial-results-for-the-fourth-quarter-and-cw9ddb5mhfn0.html
NakdEnergy
Posted - 3 days ago
@Ksmith614 feel your pain at $20, never invested here but do have some losses waiting for $ABUS to keeping winning their court cases. Bansal/ Moderna are toast eventually on this one with Pfizer being a the logical suitor for a $20 +/- BO, then MRNA has to pay Pfizer royalties. Perfect outcome with Pfizer already in working relationship with ABUS partner $ROIV, just have to wait it out.
GL!
brs555
Posted - 3 days ago
Yep. Great nut shell interpretation. Jury comes to the same conclusion...Discovery in a month. Trial a year away. $ROIV given a $5.2 billion carrot by Pfizer. $MRNA is out! Paying damages to Pfizer after $ABUS $PFE agree to some sort of buyout. Pfizer smelling like roses. Brilliant. Matt Gline smells even better! JMHO
mp3466
Posted - 6 days ago
@Catalystinvestor $NVAX up 90plus yesterday and then 15 percent today. $ABUS and $ROIV shall go up a lot more.
brs555
Posted - 1 week ago
No wonder this thing is in the shitter. $roiv to the rescue!
renoH4
Posted - 1 week ago
$ROIV just bought more, many good signs
Joe_Mama
Posted - 1 week ago
$ROIV Hitting the apex in a few weeks. Target $16.59
PatBull6912
Posted - 1 week ago
$ROIV Filed with the Court today: NOTICE OF SERVICE of Supplemental Infringement Contentions filed by Arbutus Biopharma Corporation, Genevant Sciences GmbH.(Keller, Karen) (Entered: 05/07/2024) And filed yesterday: NOTICE to Take Deposition of Stephane Bancel on May 30, 2024 filed by Arbutus Biopharma Corporation, Genevant Sciences GmbH.(Hoeschen, Nathan) (Entered: 05/06/2024) Looks like ABUS/Genevant is going for the throat!!!
DocPharm
Posted - 1 week ago
$ROIV this is going to explode like no other —
Volume before price
renoH4
Posted - 1 week ago
$ROIV... A must have
trendx
Posted - 2 weeks ago
$ROIV Forming Cup and Handle Pattern
Join Masterclass https://wa.me/918800611235
Alfalcon
Posted - 2 weeks ago
$ROIV
Jtree123
Posted - 2 weeks ago
$ROIV
DonCorleone77
Posted - 04/30/24
$ROIV Roivant Sciences put volume heavy and directionally bearish Bearish flow noted in Roivant Sciences with 1,203 puts trading, or 1.0x expected. Most active are Nov-24 10 puts and Nov-24 15 puts, with total volume in those strikes near 1,100 contracts. The Put/Call Ratio is 20.74, while ATM IV is up nearly 6 points on the day. Earnings are expected on June 28th.
Pinnacle_Capital
Posted - 04/29/24
$ROIV this company is a bitch! Pop already!
bcmcred
Posted - 04/28/24
$ROIV Trending towards $12 within the next couple weeks IMHO
Fullratio
Posted - 04/28/24
Healthcare sector stocks with high YoY EPS growth in Q4 2023: $KMDA $ROIV $OSUR
Capitulation_0
Posted - 04/26/24
$ROIV one of the best run biotechs...
Stock_Titan
Posted - 04/25/24
$ROIV Roivant and Kinevant Sciences Complete Enrollment in RESOLVE-Lung, a Phase 2 Study Evaluating Namilumab for Chronic Pulmonary Sarcoidosis
https://www.stocktitan.net/news/ROIV/roivant-and-kinevant-sciences-complete-enrollment-in-resolve-lung-a-hhgbzqpnvrzb.html
DonCorleone77
Posted - 04/24/24
$HPQ $PENN $ROIV $TECK $LBTYA Greenlight took long positions in HP, Penn Entertainment, Roivant Sciences in Q1 In the firm's Q1 letter to investors, David Einhorn's Greenlight Capital disclosed new long positions taken during the quarter, including taking stakes in HP Inc. (HPQ), Penn Entertainment (PENN) and Roivant Sciences (ROIV). In the letter, the firm stated that it established a new "medium-sized position" in Penn at an average price of $22.69 per share, arguing that "were the market to credit PENN with merely 15% of DraftKings' value, [Penn's ESPN BET] segment alone would be worth $20 per share." On HP Inc., Greenlight stated that it had established an initial position at an average price of $30.76 per share, adding that it believes "that we are, at a minimum, on the cusp of a normal PC refresh cycle, which should drive earnings above estimates." On Roivant, Greenlight said it had established a "small long position," adding that "in addition to an exciting pipeline, ROIV has a strong track record of positive trial results and successful monetization of pharmaceutical assets." Einhorn's Greenlight Capital also noted that it reduced its Teck Resources (TECK) long position into strength during Q1 and that the firm bought a "small position" in Liberty Global (LBTYA) during Q1.
DonCorleone77
Posted - 04/24/24
$ROIV Two words...Momma...shoes. Greenlight bought 'small long position' in Roivant during Q1 David Einhorn's Greenlight Capital bought a "small long position" in Roivant Sciences during Q1, according to its quarterly letter to shareholders.
ShareholderIncentives
Posted - 04/24/24
$ROIV $MRNA Genevant just filed yet another “sealed” set of documents with the Federal Court. These are regarding 30(b)(6) Disputes.
jeojackson
Posted - 04/23/24
$SOFI For those interested this 2 year chart is one of the most bullish I have seen. Picked up 1k in the morning. Yeah its not SOFI but I could not pass it up since I and so very concentrated in fictech. $ROIV
ShareholderIncentives
Posted - 04/23/24
$ROIV Genevant just filed another “sealed” letter with the Court. This time it’s related to a motion to compel discovery. Keep the pressure on Moderna!
